4th NovAliX Conference

Biophysics in Drug Discovery 2017

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Strasbourg, France    June 6-9, 2017


This year, the Scientific Programme will include the following sessions :

  • Antibodies and Relatives [antibody fragments, minibodies, nanobodies, bi- or tri-specific antibodies, ADCs, hybrid Ab-targeted protein fusions, alternate scaffolds and alternate scaffold conjugates (affinity drug conjugates), ...]
  • Biophysical Techniques for the Study of Integral Membrane Proteins (GPCRs, Ion Channels, Transporters and others)
  • Detecting Allosteric Effectors
  • Hot Topics
  • IDPs (Intrinsically Disordered Proteins) and the Dark Proteome
  • Recent Advances in FBDD [including challenging targets and HTS - FBS (fragment-based screening) combinations]
  • Recent Advances in NMR [including NMR as a (ligand co-)structure determination technology]